Dual inhibition of ERG11 and CDR2 in drug-resistant Candida albicans by Indian phytochemicals: a combined in silico-in vitro approach. [PDF]
Mundhe AK, Rajkumari R.
europepmc +1 more source
Genomic Insights of <i>Candida krusei</i>, an Emerging Fungal Pathogen With Intrinsic Antifungal Resistance. [PDF]
Jain K +5 more
europepmc +1 more source
Genomic epidemiology of Colombian resistant <i>Candida auris</i> isolates. [PDF]
Alvarado Casas ML +4 more
europepmc +1 more source
Engineering <i>Yarrowia lipolytica</i> for high-level ergosterol production. [PDF]
Liu X +7 more
europepmc +1 more source
Phenotypic and genomic characterization of azole resistance in Portuguese <i>Candida parapsilosis</i> isolates. [PDF]
Papuc AM +6 more
europepmc +1 more source
Emerging fluconazole-resistant <i>Candida parapsilosis</i> in Australia: a case cluster and insights into the genetic diversity of this species. [PDF]
Perera M +17 more
europepmc +1 more source
A quiet but growing threat: Global perspectives on antifungal resistance and future therapeutic approaches. [PDF]
Gurajala S, Challapilla M.
europepmc +1 more source
Chitosan nanoparticles loaded with ribavirin, carboplatin, and thyme oil downregulate SNQ2, ERG11, CDR1, and MDR1 in Candida strains. [PDF]
Aghaei S +4 more
europepmc +1 more source
Overcoming antifungal resistance in <i>Candida albicans via</i> RNA interference: a therapeutic perspective. [PDF]
Mundhe AK, Rajkumari R.
europepmc +1 more source

